Overslaan en naar de inhoud gaan
Novartis
language-selector-globe
Choose Location
language-selector-globeBelgium |
DutchFrançais
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Andean & CAC | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
Ukraine | українська
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe
Choose Location
language-selector-globeBelgium
DutchFrançais
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Andean & CAC | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
Ukraine | українська
United Kingdom | English
United States | English
    • Over Novartis 
      • Novartis in België 
        • Onze directie in België 
      • Strategie, missie en visie 
      • Therapeutische gebieden 
        • Cardiometabole aandoeningen en nierziekten 
          • Atherosclerose 
            • Wat is slagaderverkalking en hoe tast het ons lichaam aan? 
            • Oorzaak en risicofactoren die bijdragen aan slagaderverkalking (atherosclerose) 
            • Tijd voor actie: maak hartgezondheid een prioriteit 
        • Neurologie 
        • Immunologie 
        • Oncologie 
          • Radioligandtherapie (RLT): nucleaire precisiegeneeskunde vernieuwt kankerzorg 
      • Innovatieve geneesmiddelen 
        • Onze pijplijn 
      • Inclusie 
      • Mensen & Cultuur 
      • Contact 
      Meisje met een bloem
      Over
    • Patiënten en mantelzorgers 
      • Onze samenwerking met Belgische patiëntenverenigingen 
      • Toegang tot zorg 
      couple holding hands
      Patiënten en mantelzorgers
    • Zorgverleners 
      • Zorgverlenerportaal 
      • Klinische proeven van Novartis 
      • Subsidie aanvragen 
      • Melding maken 
      Twee vrouwelijke artsen
      Zorgverleners
    • Onze impact 
      • Duurzaamheid 
      • Onze impact in België 
      • Onze inzet 
      • Onze ethische gedragscode 
      • Ethiek, risico en naleving 
      Ons ESG-engagement
      Onze impact
    • Nieuws 
      • Nieuws 
      • Perscontact 
      Een foto van mensen in een vergaderruimte
      Nieuws
    • Jobs 
      • Werken bij Novartis België 
      • Openstaande vacatures bij Novartis 
      • Waarom Novartis? 
      • Novartis-sites in België 
        • Werken voor Novartis in Puurs 
        • Werken voor Novartis in Vilvoorde 
      • Ontmoet onze teams 
        • Werken in Supply Chain 
        • Werken in Manufacturing 
        • Werken in Quality 
        • Werken als Young Graduate 
        • Werken in Business Services 
        • Werken in Sales & Marketing 
        • Werken in Medical Science 
        • Werken in Market Access 
      Jobs
      Jobs
    Wetenschapper schrijft op glazen wand
    Home
  1. Home
  2. Jobs
  3. Openstaande vacatures bij Novartis
  • Sort by Sort ascending
  • Functie titel Oplopend sorteren
  • Site
  • Plaats
  • Afdeling
  • Bedrijf
  • Functional Area
  • Datum geplaatst
Functie titel Oplopend sorteren Site Plaats Afdeling Bedrijf Functional Area Datum geplaatst
Head Legal Medical Affairs, International Basel (City) Switzerland Legal Legal Legal & Intellectual Property & Compl. 14 Januari 2026
Market Access Manager (80-100%*) (temp role 12 months) Rotkreuz (Office-Based) Switzerland International Strategic Planning & BD&L Market Access 13 Januari 2026
Equipment Operator (befristet – 2 Jahre) -Schichtarbeit (6/4 Schichtmodell) Muttenz (with Canteen) Switzerland Operations Production / Manufacturing Technical Operations 13 Januari 2026
Market Access Manager (80-100%*) (temp role 12 months) Rotkreuz (Office-Based) Switzerland International Strategic Planning & BD&L Market Access 13 Januari 2026
Associate Director - Foundry Solution Architecture, Full Stack & AIP Cambridge (USA) USA Biomedical Research Research Research & Development 13 Januari 2026
Market Access Manager (80-100%*) (temp role 12 months) Rotkreuz (Office-Based) Switzerland International Strategic Planning & BD&L Market Access 13 Januari 2026
Market Access Manager (80-100%*) (temp role 12 months) Rotkreuz (Office-Based) Switzerland International Strategic Planning & BD&L Market Access 13 Januari 2026
Market Access Manager (80-100%*) (temp role 12 months) Rotkreuz (Office-Based) Switzerland International Strategic Planning & BD&L Market Access 13 Januari 2026
Market Access Manager (80-100%*) (temp role 12 months) Rotkreuz (Office-Based) Switzerland International Strategic Planning & BD&L Market Access 13 Januari 2026
Market Access Manager (80-100%*) (temp role 12 months) Rotkreuz (Office-Based) Switzerland International Strategic Planning & BD&L Market Access 13 Januari 2026
Market Access Manager (80-100%*) (temp role 12 months) Rotkreuz (Office-Based) Switzerland International Strategic Planning & BD&L Market Access 13 Januari 2026
Market Access Manager (80-100%*) (temp role 12 months) Rotkreuz (Office-Based) Switzerland International Strategic Planning & BD&L Market Access 13 Januari 2026
Market Access Manager (80-100%*) (temp role 12 months) Rotkreuz (Office-Based) Switzerland International Strategic Planning & BD&L Market Access 13 Januari 2026
Market Access Manager (80-100%*) (temp role 12 months) Rotkreuz (Office-Based) Switzerland International Strategic Planning & BD&L Market Access 13 Januari 2026
Global Program Safety Lead London (The Westworks) United Kingdom Development Development Research & Development 12 Januari 2026
Medical Lead Cardio Renal Metabolic (CRM) Rotkreuz (Office-Based) Switzerland International Development Research & Development 09 Januari 2026
(Senior) Clinical Development Director - CV Basel (City) Switzerland Development Development Research & Development 08 Januari 2026
Senior Expert Radioligand Parenteral Packaging Technology (m/f/d) Schaftenau Austria Development Development Research & Development 08 Januari 2026
Intern in Medical Device Development – Mechanical Engineering Basel (City) Switzerland Development Development Others 07 Januari 2026
MSL Radioligand Therapy Rotkreuz (Field-Based) Switzerland International Development Research & Development 18 December 2025
Senior Expert Engineering – Assembly for Medical Device Basel (City) Switzerland Development Development Research & Development 11 December 2025
Expert Engineering – Medical Device Development Basel (City) Switzerland Development Development Research & Development 11 December 2025
Analytical Project Leader (m/f/d) Basel (City) Switzerland Development Development Research & Development 11 December 2025
Site Quality Head Basel (Land) Switzerland Operations Quality Quality 10 December 2025
Process Technician - Supply Management Basel (City) Switzerland Development Development Research & Development 03 December 2025
Senior Patent Litigation Paralegal Basel (City) Switzerland Legal Legal Legal & Intellectual Property & Compl. 21 November 2025
Principal Scientist, Mid/Large Scale Oligonucleotide Synthesis, xRNA Therapeutics Basel (City) Switzerland Biomedical Research Research Research & Development 18 November 2025
Key Account Manager Radioligand Therapy (Prostate Cancer), Central West Rotkreuz (Field-Based) Switzerland International Marketing Sales 04 November 2025
Patient Centered Outcomes HTA, TA Director Basel (City) Switzerland International Marketing Market Access 01 Oktober 2025
HTA Evidence Synthesis Statistician Basel (City) Switzerland International Marketing Market Access 15 September 2025
No matching countries found
Zoeken

Novartis België

Direct naar
  • Over Novartis
  • Bijwerking melden
  • Werken bij Novartis
  • Onze impact
  • Contact
Mediacentrum
  • Mediacontacten
  • Nieuws
Ons portfolio
  • Innovatie
Andere websites van Novartis
  • Zorgverlenersportaal
  • Novartis Global
Onder footer
© 2026 Novartis AG
  • Privacybeleid
  • Gebruiksvoorwaarden
  • Toegankelijkheid
  • Algemene inkoop voorwaarden
  • Algemene Verkoopsvoorwaarden
  • Cookie-instellingen
  • Sitemap
Novartis Site Directory
Deze website is bestemd voor inwoners van België